MEHLMAN CONSULTING, INC. for VIZIENT INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare coverage; prescription drug costs; group purchasing issues; drug shortage issues. S. 773 - 340B Drug Pricing Program. COVID-19 supply chain and pharmaceutical, PPE, and other health care supply chain issues. S. 3799 - PREVENT Pandemics Act. Environmental issues related to Health Care Providers and Health Care Services. H.R. 2617 - Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| DEAN ROSEN | — |
Medicare/Medicaid MMM
Healthcare transparency, costs and access to affordable medication and other healthcare items and services. H.R. 2617 - Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN ARONSON | — |
| DEAN ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.